Cleveland Clinic Abu Dhabi, United Kingdom
Prof Tamas Szakmany MD, PhD, EDIC, DESA, FCCM is Consultant in Intensive Care Medicine and Vice-Chair of Research for the Integrated Hospital Care Institute at Cleveland Clinic Abu Dhabi. He graduated at the University of Pecs, Hungary, where he then went on to gain his PhD in Critical Care. As a practicing clinician he still spends most of his time at the bedside, whilst he leads multidisciplinary and multi-institutional research projects. He has been an active member of the Society of Critical Care Medicine since 2012, a founding member of the Social Media Committee, member of the Congress Program Committee and Co-Chair of the 2024 SCCM Congress. Tamas is the current Editor-in-Chief of SCCM's open access journal, Critical Care Explorations.
Tamas’s research interests have always encompassed a broad spectrum of critical care practices: from monitoring and modulation of inflammatory response in sepsis and after major surgery to long-term outcomes following critical care discharge and also participating actively in large randomized controlled trials. During the COVID-19 pandemic his work concentrated on phenotyping COVID19 ARDS and leading the RECOVERY and REMAP-CAP trials for his previous organization in the UK.
Tamas has always been passionate to work with medical students and early career researchers, to help them realizing their potential: his last few publications are all collaborations with medical students at Cardiff University with whom he developed an award-winning research programme on the epidemiology of sepsis on the general wards. He has been awarded the Member of the British Empire (MBE) title at the Queen's New Year's Honours in 2021, for his work during the COVID-19 pandemic.
Changing Nutrition Practice in Critical Care: Bridging Policy and Historical Context in the NHS
Sunday, March 22, 2026
12:15 PM - 1:15 PM Central Time
Disclosure information not submitted.
Connect and Converse: Increase Your Impact Through SCCM Journals
Monday, March 23, 2026
10:15 AM - 11:00 AM Central Time
Disclosure(s): Biotest AG: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 31, 2024)
New-Onset Atrial Fibrillation and Treatment Strategies: Retrospective Analysis of AmsterdamUMCdb
Monday, March 23, 2026
2:30 PM - 3:30 PM Central Time
Disclosure information not submitted.
Centralizing Out-of-Hospital Cardiac Arrest Pathways for Patients in Wales, UK: Room for Improvement
Tuesday, March 24, 2026
8:45 AM - 9:45 AM Central Time
Disclosure information not submitted.
The Impact of ICU Follow-Up Clinic on Healthcare Utilization: A Population-Level Data-Linkage Study
Tuesday, March 24, 2026
10:00 AM - 11:00 AM Central Time
Disclosure information not submitted.